WuXi AppTec’s Castle Biosciences CSTL Stock Holding History

WuXi AppTec’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,636	Closed	-$143K	–	3
2023 Q4	$143K	Buy	+6,636	New	+$117K	0.37%	5

Other funds holding CSTL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

WuXi AppTec's CSTL Position: Q1 2024 in Review

WuXi AppTec sold out of Castle Biosciences (CSTL) in Q1 2024, closing a stake of 6,636 shares — an estimated $143K sold.

WuXi AppTec first reported a position in CSTL in Q4 2023 and held it in 1 quarter. The position peaked at $143K in Q4 2023. 151 funds tracked by Wall St. Rank hold CSTL as of Q1 2024.

WuXi AppTec reported no remaining Castle Biosciences position as of Q1 2024 after selling out during the quarter.
WuXi AppTec sold 6,636 Castle Biosciences shares in Q1 2024, an estimated $143K.
WuXi AppTec first reported a position in Castle Biosciences in Q4 2023 and held it in 1 quarter.
WuXi AppTec's Castle Biosciences position peaked at $143K in Q4 2023.
151 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2024.

Based on WuXi AppTec's 13F filing for Q1 2024, filed 7 May 2024.